Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Edmund P. Harrigan"'
Publikováno v:
EquityBites (M2). 12/01/2015.
Publikováno v:
Biotech Week; 7/31/2002, p25, 1p
Autor:
J.J. Miceli, Karen R. Reeves, Watsky Eric Jacob, Neal R. Cutler, T. John Sramek, Michelle Middle, R.J. Anziano, Edmund P. Harrigan, Thomas Shiovitz
Publikováno v:
Journal of Clinical Psychopharmacology. 24:62-69
Many drugs have been associated with QTc prolongation and, in some cases, this is augmented by concomitant administration with metabolic inhibitors. The effects of 6 antipsychotics on the QTc interval at and around the time of estimated peak plasma/s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be7f6d7761d50af7773fc9857b6b91c3
https://doi.org/10.1097/01.jcp.0000104913.75206.62
https://doi.org/10.1097/01.jcp.0000104913.75206.62
Publikováno v:
Progress in Cardiovascular Diseases. 43:1-45
The effects of disease states and therapeutic drugs on the QT interval have been extensively studied in an attempt to understand the relationship between QT and the risk of torsade de pointes and sudden cardiac death. Differences in heart rate correc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dbc479f5e51a0c78ea2ddffc52dfb4c
https://doi.org/10.1053/pcad.2001.21469
https://doi.org/10.1053/pcad.2001.21469
Publikováno v:
Psychopharmacology. 155:128-134
Rationale: Intramuscular (IM) conventional antipsychotics and/or benzodiazepines are effective in the short-term treatment of acutely agitated psychotic patients but may be associated with adverse effects. A short-acting IM formulation of the novel a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374a73df93aa7a4114bcf5efd25b97a0
https://doi.org/10.1007/s002130000658
https://doi.org/10.1007/s002130000658
Publikováno v:
Journal of Clinical Psychopharmacology. 21:27-35
This study assessed the efficacy of ziprasidone for the treatment of schizoaffective disorder. Data were taken from subsets of patients with schizoaffective disorder, derived from two separate double-blind, placebo-controlled, parallel-group, multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b12242452e33e3f3d958dcd33b873028
https://doi.org/10.1097/00004714-200102000-00007
https://doi.org/10.1097/00004714-200102000-00007
Autor:
David G. Daniel, Steven G. Potkin, Mani Lakshminarayanan, Karen R. Reeves, Edmund P. Harrigan, Dan L. Zimbroff
Publikováno v:
Neuropsychopharmacology. 20:491-505
In this double-blind study, patients with an acute exacerbation of schizophrenia or schizoaffective disorder were randomized to receive either ziprasidone 80 mg/day (n = 106) or 160 mg/day (n = 104) or placebo (n = 92), for 6 weeks. Both doses of zip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7aab7924a76f4d375959e7c76901392
https://doi.org/10.1016/s0893-133x(98)00090-6
https://doi.org/10.1016/s0893-133x(98)00090-6
Autor:
Feighner Jp, Marilyn R. Morrissey, Alan Buffenstein, Edmund P. Harrigan, James Ferguson, William Jaffe, Paul E. Keck
Publikováno v:
Psychopharmacology. 140:173-184
A double-blind, placebo-controlled, multicenter study, was performed to evaluate the efficacy and safety of ziprasidone in 139 patients with an acute exacerbation of schizophrenia or schizoaffective disorder. Patients were randomized to receive zipra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce42302622e92c611e1993538a59b9b0
https://doi.org/10.1007/s002130050755
https://doi.org/10.1007/s002130050755
Publikováno v:
International clinical psychopharmacology. 19(1)
The intramuscular (i.m.) formulation of ziprasidone offers promise as an alternative to conventional i.m. agents for the short-term management of agitated patients with psychosis. This 7-day, randomized, open-label study evaluated the tolerability of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8177b1af830452e663c59f860b2b285
https://pubmed.ncbi.nlm.nih.gov/15101564
https://pubmed.ncbi.nlm.nih.gov/15101564